LEXARIA BIOSCIENCE CORP. Assets, Noncurrent
LEXARIA BIOSCIENCE CORP. (LEXX) had Assets, Noncurrent of $716.46 thousand as of 2026-05-31, per its 10-Q filed 2026-07-13.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:AssetsNoncurrent · last filed 2026-07-13
- 2026-05-31: Assets, Noncurrent $716.46K.
- 2026-02-28: Assets, Noncurrent $717.02K.
- 2025-11-30: Assets, Noncurrent $687.68K.
- 2025-08-31: Assets, Noncurrent $706.78K.
| Period end | Assets, Noncurrent | Assets, Noncurrent as first filed |
|---|---|---|
| 2026-05-31 | $716.46K 10-Q · filed 2026-07-13 | |
| 2026-02-28 | $717.02K 10-Q · filed 2026-04-13 | |
| 2025-11-30 | $687.68K 10-Q · filed 2026-01-13 | |
| 2025-08-31 | $706.78K 10-Q · filed 2026-07-13 | |
| 2025-05-31 | $934.59K 10-Q · filed 2025-07-14 | |
| 2025-02-28 | $953.17K 10-Q · filed 2025-04-14 | |
| 2024-11-30 | $968.03K 10-Q · filed 2025-01-10 | |
| 2024-08-31 | $969.80K 10-K · filed 2025-11-28 | |
| 2024-05-31 | $925.06K 10-Q · filed 2024-07-12 | |
| 2024-02-29 | $935.06K 10-Q · filed 2024-04-09 | |
| 2023-11-30 | $933.14K 10-Q · filed 2024-01-12 | |
| 2023-08-31 | $932.77K 10-K · filed 2024-11-26 | $884.21K 10-K · filed 2023-11-20 |
| 2023-05-31 | $1.00M 10-Q · filed 2023-07-14 | |
| 2023-02-28 | $851.20K 10-Q · filed 2023-04-14 | |
| 2022-11-30 | $854.11K 10-Q/A · filed 2023-01-18 | |
| 2022-08-31 | $856.41K 10-K · filed 2023-11-20 | |
| 2022-05-31 | $846.47K 10-Q · filed 2022-07-14 | |
| 2022-02-28 | $842.36K 10-Q · filed 2022-04-11 | |
| 2021-11-30 | $844.55K 10-Q · filed 2022-01-14 | |
| 2021-08-31 | $823.88K 10-K · filed 2022-11-28 | |
| 2021-05-31 | $861.99K 10-Q · filed 2021-07-15 | |
| 2021-02-28 | $1.23M 10-Q · filed 2021-04-14 | |
| 2020-11-30 | $866.61K 10-Q · filed 2021-01-14 | |
| 2020-08-31 | $902.28K 10-K · filed 2021-11-29 | |
| 2020-05-31 | $792.15K 10-Q · filed 2020-06-29 | |
| 2020-02-29 | $806.18K 10-Q · filed 2020-04-03 | |
| 2019-11-30 | $834.59K 10-Q · filed 2020-01-09 | |
| 2019-08-31 | $856.39K 10-K · filed 2020-10-15 | |
| 2019-05-31 | $849.50K 10-Q · filed 2019-07-08 | |
| 2018-11-30 | $313.37K 10-Q · filed 2019-01-11 | |
| 2018-08-31 | $147.78K 10-K · filed 2019-11-14 | |
| 2018-05-31 | $121.96K 10-Q · filed 2018-07-13 | |
| 2018-02-28 | $95.89K 10-Q · filed 2018-04-12 | |
| 2017-11-30 | $80.02K 10-Q · filed 2018-01-12 | |
| 2017-08-31 | $64.68K 10-K · filed 2018-11-14 | |
| 2017-05-31 | $65.06K 10-Q · filed 2017-07-14 | |
| 2017-02-28 | $65.43K 10-Q · filed 2017-04-14 | |
| 2016-11-30 | $69.78K 10-Q · filed 2017-01-13 | |
| 2016-08-31 | $56.47K 10-K · filed 2017-11-27 | |
| 2016-05-31 | $51.89K 10-Q · filed 2016-07-13 | |
| 2016-02-29 | $52.04K 10-Q · filed 2016-04-13 | |
| 2015-08-31 | $36.99K 10-K · filed 2016-11-29 | |
| 2015-05-31 | $40.95K 10-Q · filed 2015-07-14 | |
| 2014-08-31 | $67.66K 10-K · filed 2015-11-27 | |
| 2014-07-31 | $3.37M 10-Q · filed 2014-11-14 | |
| 2013-10-31 | $3.43M 10-KT · filed 2014-12-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |